Augmentation of Human Immunodeficiency Virus Type 1 Gene Expression by Tumor Necrosis Factor α

AIDS Research and Human Retroviruses

Volumn 5, Issue 2, 1989, Pages 131-138

  Okamoto, Takashi ^a   Matsuyama, Toshifumi ^a,b   Mori, Shigehisa ^a   Hamamoto, Yoshiaki ^b   Kobayashi, Nobuyuki ^b   Yamamoto, Naoki ^b   Josephs, Steven F ^c   Wong Staal, Flossie ^c   Shimotohno, Kunitada ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CELL CULTURE; GENE EXPRESSION; GENETIC ENGINEERING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1;

ANIMAL; CHLORAMPHENICOL O-ACETYLTRANSFERASE; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION; HIV-1; HUMAN; PLASMIDS; RNA, MESSENGER; RNA, VIRAL; SUPPORT, NON-U.S. GOV'T; TRANSFECTION; TUMOR NECROSIS FACTOR;

EID: 0024538721     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.1989.5.131     Document Type: Article

References (29)

1. Goudsmit J, De Wolf F, Paul DA, Epstein LG, Lange JMA, Krone WJA, Speelman H, Wolters ECH, Van Der Noordaa J, Oleske JM, Van Der Helm HJ, and Coutinho RA: Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet 1986;2:177–180.
2. Lange JMA, Paul DA, Huisman HG, De Wolf F, Van Den Berg H, Coutinho RE, Danner SA, Van Der Noordaa J, and Goudsmit J: Persistent HIV antigenemia and decline of HIV core antibodies associated with transition to AIDS. Br Med J 1986;293:1459–1462.
3. Harada S, Koyanagi Y, Nakashima H, Kobayashi N, and Yamamoto N: Tumor promoter, TPA, enhances replication of HTLV-III/LAV. Virology 1986;154:249–258.
4. Dinter H, Chiu R, Imagawa M, Karin M, and Jones KA: In vitro activation of the HIV-1 enhances in extracts from cells treated with a phorbol ester tumor promoter. EMBO J 1987;6:4067–4071.
5. Folks TM, Justement J, Kinter A, Dinarello CA, and Fauci AS: Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 1987;238:800–802.
6. Zagury D, Bernard J, Leonard R, Cheynier R, Feldman M, Sarin PS, Gallo RC: Long-term cultures of HTLV-III-infected T cells: A model of cytopathology of T-cell depletion in AIDS. Science 1986;231:850–853.
7. Nabel G and Baltimore D: An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 1987;326:711–713.
8. Böhnlein E, Lowenthal JW, Siekevitz M, Ballard DW, Franza BR, and Greene WC: The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV. Cell 1988;53:827–836.
9. Siekevitz M, Josephs SF, Dukovich M, Peffer N, Wong-Staal F, and Greene WC: Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I. Science 1987;238:1575–1578.
10. Valerie K, Delers A, Bruck C, Thiriart C, Rosenberg H, Debouck C, and Rosenberg M: Activation of human immunodeficiency virus type 1 by DNA damage in human cells. Nature 1988;333:78–81.
11. Gendelman HE, Phelps W, Feigenbaum L, Ostrive JM, Adachi A, Howley PM, Khoury G, Ginsberg HS, and Martin M: Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc Natl Acad Sci USA 1986;83:9759–9763.
12. Mosca JD, Bednarik DP, Raj NBK, Rosen CA, Sodroski JG, Haseltine WA, and Pitha PM: Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus. Nature 1987;325:67–70.
13. Harada S, Koyanagi Y, and Yamamoto N: Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 1985;229:563–566.
14. De Rossi A, Franchini G, Aldovini A, Del Mistro A, Chieco-Bianchi L, Gallo RC, Wong-Staal F: Differential response to the cytopathic effects of human T-cell lymphotrpic virus type III(HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I. Proc Natl Acad Sci USA 1986;83:4297–4301.
15. Kikukawa R, Koyanagi Y, Harada S, Kobayashi N, Hatanaka M, and Yamamoto N: Differential suscepttbility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4. J Virol 1986;57:1159–1162.
16. Koyanagi Y, Harada S, Takahashi M, Uchino F, and Yamamoto N: Selective cytotoxicity of AIDS virus infection towards HTLV-I-transformed cell lines. Int J Cancer 1985;36:445–451.
17. Okamoto T, Akagi T, Shima H, Miwa M, and Shimotohno K: Superinduction of trans-activation accounts for augmented human immunodeficiency virus replication in HTLV-I-transformed cells. Jpn J Cancer Res (Gann) 1987;78:1297–1301.
18. Montefiori DC and Mitchell WM: Infection of the HTLV-II-bearing T-cell line C3 with HTLV-III/LAV is highly permissive and lytic. Virology 1986;155:726–731.
19. Matsuyama T, Hamamoto Y, Yoshida T, Kido Y, Kobayashi S, Kobayashi N, and Yamamoto N: Effect of culture supernatant of MT-2 cells on human immunodeficiency virus-producing cells, MOLT-4/HIV/HTLV-IIIB cells. Jpn J Cancer Res (Gann) 1988;79:156–159.
20. Okamoto T and Wong-Staal F: Demonstration of virus-specific transcriptional activator(s) in cells infected with HTLV-III by an in vitro cell-free system. Cell 1986;47:29–35.
21. Rosen CA, Sodroski JG, and Haseltine WA: The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 1985;41:813–823.
22. Shimotohno K, Takano M, Teruuchi T, and Miwa M: Requirement of multiple copies of a 21-nucleotide sequence in the U3 regions of human T-cell leukemia virus type I and type II long terminal repeats for trans-acting activation of transcription. Proc Natl Acad Sci USA 1986;83:8112–8116.
23. Ishii S, Merlino GT, and Pastan I: Promoter region of the human Harvey ras proto-oncogene: Similarity to the EGF receptor proto-oncogene promoter. Science 1985;230:1378–1381.
24. Arya SK, Guo C, Josephs SF, and Wong-Staal F: Trans-activator of human T-lymphotropic virus type III (HTLV-III). Science 1985;229:69–73.
25. Favaloro J, Treisman R, and Kamen R: Transcription maps of polyoma virus-specific RNA: Analysis by two-dimensional nuclease S1 gel mapping. Methods Enzymol 1980;65:718–749.
26. Okamoto T, Josephs SF, Kawanishi M, and Wong-Staal F: Determination of a splice acceptor site of pX gene in HTLV-1 infected cells. Virology 1985;143:636–639.
27. Jones KA, Kadonaga T, Luciw PA, and Tjian R: Activation of the AIDS retrovirus promoter by the cellular transcription factor, SP1. Science 1986;232:755–759.
28. Wu FK, Garcia JA, Harrich D, and Gaynor RB: Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1. EMBO J 1988;7:2117–2129.
29. Hackett RJ, Davis LS, and Lipsky PE: Comparative effects of tumor necrosis factor-α and IL-lβ on mitogen-in-duced T cell activation. J Immunol 1988;140:2639–2644.